A promoter reported in cDNA corresponding to IRES sequence: no (not convincing)
The total number of notable open-reading frames (ORFs): 1
Summary of possible issues when IRES cDNA is experimentally transcribed in vivo:
Summary of experiments studying integrity of the in vivo transcripts in a particular host:
Integrity (uniformity) of mRNA tested using Northern-blot: homogeneous_population_of_molecules_confirmed
Integrity (uniformity) of mRNA tested using RNase protection: not_tested
Integrity (uniformity) of mRNA tested using 5'-RACE: not_tested
Integrity (uniformity) of mRNA tested using primer extension : not_tested
Integrity (uniformity) of mRNA tested using RT-PCR: not_tested
Integrity (uniformity) of mRNA tested using real-time quantitative polymerase chain reaction (rtqPCR): not_tested
Integrity (uniformity) of mRNA tested using RNAi: not_tested
Integrity (uniformity) of mRNA tested using S1 nuclease mapping: not_tested
Cryptic promoter presence was confirmed by expression from a promoter-less plasmid: not_tested
Cryptic promoter presence was confirmed in an experimental setup involving inducible promoter: not_tested
Integrity (uniformity) of mRNA molecules or possible promoter presence expressed in vivo was tested using another method, please specify in Remarks: not_tested
The description of the protein encoded in this ORF: cationic amino acid transporter 1 (arginine/lysine)
The translational frameshift (ribosome slippage) involved: 0
The ribosome read-through involved: no
The alternative forms of this protein occur by the alternative initiation of translation: not tested
The ORF absolute position (the base range includes START and STOP codons or their equivalents): 271-2145
Remarks:
The first 60bp have been added in front of GI:33943114 from GI:18542255. The leftmost 45 nt were not
determined by authors by 5'-RACE as shown in Fernandez et al. (2001), Figure 1A. Additional primer-extension
studies were published in Fernandez et al. (2003) in Figure 2A and have identified transcription start site
'G' residues -254 and -260 nt upstream of initiator ATG. The mRNA sequence used here in IRESite is the one
defined by S1 nuclease protection as shown in Fernandez et al. (2003) in Figure 2B,D (black arrow) and is
longer by 10 or 16 nt then the transcripts mapped by primer-extension (gray arrows).